131 related articles for article (PubMed ID: 38176993)
1. Prostate-specific Membrane Antigen-targeted Isotope Therapy: Inherent Challenges Owing to Heterogeneity and Clonal Evolution.
Sartor O
Eur Urol; 2024 Mar; 85(3):205-206. PubMed ID: 38176993
[No Abstract] [Full Text] [Related]
2. The heterogeneity and clonal evolution analysis of the advanced prostate cancer with castration resistance.
Liu A; Gao Y; Wang Q; Lin W; Ma Z; Yang X; Chen L; Xu D
J Transl Med; 2023 Sep; 21(1):641. PubMed ID: 37726835
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer: Multifocal disease--independent clonal lineages in malignant nodules and even in normal tissue.
Thoma C
Nat Rev Urol; 2015 Apr; 12(4):177. PubMed ID: 25782174
[No Abstract] [Full Text] [Related]
4. Intratumoral heterogeneity and genetic characteristics of prostate cancer.
Wu B; Lu X; Shen H; Yuan X; Wang X; Yin N; Sun L; Shen P; Hu C; Jiang H; Wang D
Int J Cancer; 2020 Jun; 146(12):3369-3378. PubMed ID: 32159858
[TBL] [Abstract][Full Text] [Related]
5. The Heterogeneity of Prostate Cancer: A Practical Approach.
Tolkach Y; Kristiansen G
Pathobiology; 2018; 85(1-2):108-116. PubMed ID: 29393241
[TBL] [Abstract][Full Text] [Related]
6. Intratumor DNA methylation heterogeneity reflects clonal evolution in aggressive prostate cancer.
Brocks D; Assenov Y; Minner S; Bogatyrova O; Simon R; Koop C; Oakes C; Zucknick M; Lipka DB; Weischenfeldt J; Feuerbach L; Cowper-Sal Lari R; Lupien M; Brors B; Korbel J; Schlomm T; Tanay A; Sauter G; Gerhäuser C; Plass C;
Cell Rep; 2014 Aug; 8(3):798-806. PubMed ID: 25066126
[TBL] [Abstract][Full Text] [Related]
7. Clonal origin and spread of metastatic prostate cancer.
Van Etten JL; Dehm SM
Endocr Relat Cancer; 2016 Apr; 23(4):R207-17. PubMed ID: 27000662
[TBL] [Abstract][Full Text] [Related]
8. Unraveling the clonal hierarchy of somatic genomic aberrations.
Prandi D; Baca SC; Romanel A; Barbieri CE; Mosquera JM; Fontugne J; Beltran H; Sboner A; Garraway LA; Rubin MA; Demichelis F
Genome Biol; 2014 Aug; 15(8):439. PubMed ID: 25160065
[TBL] [Abstract][Full Text] [Related]
9. [Hormone Resistance and Neuroendocrine Differentiation Due to Accumulation of Genetic Lesions during Clonal Evolution of Prostate Cancer].
Mikhaylenko DS; Efremov GD; Sivkov AV; Zaletaev DV
Mol Biol (Mosk); 2016; 50(1):34-43. PubMed ID: 27028809
[TBL] [Abstract][Full Text] [Related]
10. Spatial Intratumor Genomic Heterogeneity within Localized Prostate Cancer Revealed by Single-nucleus Sequencing.
Su F; Zhang W; Zhang D; Zhang Y; Pang C; Huang Y; Wang M; Cui L; He L; Zhang J; Zou L; Zhang J; Li W; Li L; Shao J; Ma J; Xiao F; Liu M
Eur Urol; 2018 Nov; 74(5):551-559. PubMed ID: 29941308
[TBL] [Abstract][Full Text] [Related]
11. Genomic Heterogeneity Within Individual Prostate Cancer Foci Impacts Predictive Biomarkers of Targeted Therapy.
VanderWeele DJ; Finney R; Katayama K; Gillard M; Paner G; Imoto S; Yamaguchi R; Wheeler D; Lack J; Cam M; Pontier A; Nguyen YTM; Maejima K; Sasaki-Oku A; Nakano K; Tanaka H; Vander Griend D; Kubo M; Ratain MJ; Miyano S; Nakagawa H
Eur Urol Focus; 2019 May; 5(3):416-424. PubMed ID: 29398457
[TBL] [Abstract][Full Text] [Related]
12. Is high-grade prostatic intraepithelial neoplasia (HGPIN) a reliable precursor for prostate carcinoma? Implications for clonal evolution and early detection strategies.
Tolkach Y; Kristiansen G
J Pathol; 2018 Apr; 244(4):389-393. PubMed ID: 29377129
[TBL] [Abstract][Full Text] [Related]
13. High-resolution genome-wide copy-number analysis suggests a monoclonal origin of multifocal prostate cancer.
Boyd LK; Mao X; Xue L; Lin D; Chaplin T; Kudahetti SC; Stankiewicz E; Yu Y; Beltran L; Shaw G; Hines J; Oliver RT; Berney DM; Young BD; Lu YJ
Genes Chromosomes Cancer; 2012 Jun; 51(6):579-89. PubMed ID: 22334418
[TBL] [Abstract][Full Text] [Related]
14. Isotope selection for patients undergoing prostate brachytherapy.
Cha CM; Potters L; Ashley R; Freeman K; Wang XH; Waldbaum R; Leibel S
Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):391-5. PubMed ID: 10487561
[TBL] [Abstract][Full Text] [Related]
15. A Systematic Review of Prostate Cancer Heterogeneity: Understanding the Clonal Ancestry of Multifocal Disease.
Erickson A; Hayes A; Rajakumar T; Verrill C; Bryant RJ; Hamdy FC; Wedge DC; Woodcock DJ; Mills IG; Lamb AD
Eur Urol Oncol; 2021 Jun; 4(3):358-369. PubMed ID: 33888445
[TBL] [Abstract][Full Text] [Related]
16. Imaging of Prostate Specific Membrane Antigen Targeted Radiotracers for the Detection of Prostate Cancer Biochemical Recurrence after Definitive Therapy: A Systematic Review and Meta-Analysis.
Tan N; Bavadian N; Calais J; Oyoyo U; Kim J; Turkbey IB; Mena E; Davenport MS
J Urol; 2019 Aug; 202(2):231-240. PubMed ID: 30829130
[TBL] [Abstract][Full Text] [Related]
17. Clonal Evolution and Epithelial Plasticity in the Emergence of AR-Independent Prostate Carcinoma.
Laudato S; Aparicio A; Giancotti FG
Trends Cancer; 2019 Jul; 5(7):440-455. PubMed ID: 31311658
[TBL] [Abstract][Full Text] [Related]
18. Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis.
Mayrhofer M; De Laere B; Whitington T; Van Oyen P; Ghysel C; Ampe J; Ost P; Demey W; Hoekx L; Schrijvers D; Brouwers B; Lybaert W; Everaert E; De Maeseneer D; Strijbos M; Bols A; Fransis K; Oeyen S; van Dam PJ; Van den Eynden G; Rutten A; Aly M; Nordström T; Van Laere S; Rantalainen M; Rajan P; Egevad L; Ullén A; Yachnin J; Dirix L; Grönberg H; Lindberg J
Genome Med; 2018 Nov; 10(1):85. PubMed ID: 30458854
[TBL] [Abstract][Full Text] [Related]
19. Positron Emission Tomography/Computed Tomography with Gallium-68-labeled Prostate-specific Membrane Antigen Detects Relapse After Vascular-targeted Photodynamic Therapy in a Prostate Cancer Model.
Alvim R; Nagar K; Das S; Lebdai S; Wong N; Somma A; Hughes C; Thomas J; Monette S; Scherz A; Kim K; Grimm J; Coleman JA
Eur Urol Focus; 2021 Mar; 7(2):472-478. PubMed ID: 31227464
[TBL] [Abstract][Full Text] [Related]
20. A telomerase-immortalized primary human prostate cancer clonal cell line with neoplastic phenotypes.
Gu Y; Kim KH; Ko D; Nakamura K; Yasunaga Y; Moul JW; Srivastava S; Arnstein P; Rhim JS
Int J Oncol; 2004 Oct; 25(4):1057-64. PubMed ID: 15375556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
